Lidocaine HCl Injection — Class I drug recall D-1278-2014
Terminated recall by Hospira Inc., reported 2014-05-07, distributed nationwide. Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in
| Recall number | D-1278-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-12-23 |
| Classified | 2014-04-27 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2014-10-07 |
| Distributed | Nationwide (US) |
| Quantity | 68,350 vials |
| Reason classes | foreign material, specification failure |
| NDC | 00409-2066, 00409-2066-05, 00409-2066-10 |
| Lot numbers | 08/15, 32135DD |
Product
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.
Reason for recall
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1278-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.